Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
Diabetologia
|
April 30, 2008
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
A Sandbaek, S J Griffin, G Rutten, et al.
Diabetologia
|
January 30, 2008
Polymorphisms in AHI1 are not associated with type 2 diabetes or related phenotypes in Danes: non-replication of a genome-wide association result
J Holmkvist, S Anthonsen, L Wegner, et al.
Diabetes, Obesity & Metabolism
|
April 13, 2010
Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus
S B Petersen, J Kildegaard, F S Nielsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 5, 2014
Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial
R K Simmons, A H Carlsen, S J Griffin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 10, 2016
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus
T M Jensen, D Vistisen, T Fleming, et al.
Diabetologia
|
April 25, 2013
The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status
A Heraclides, T M Jensen, S S Rasmussen, et al.
Diabetologia
|
November 19, 2011
Common variation in oxidative phosphorylation genes is not a major cause of insulin resistance or type 2 diabetes
L S Snogdal, M Wod, N Grarup, et al.
Diabetologia
|
May 1, 2009
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction
T Sparsø, N Grarup, C Andreasen, et al.
Diabetologia
|
June 24, 2008
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation
T Sparsø, G Andersen, A Albrechtsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 13, 2015
The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study
C S Hansen, T M Jensen, J S Jensen, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
Diabetologia
|
April 30, 2008
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
A Sandbaek, S J Griffin, G Rutten, et al.
Diabetologia
|
January 30, 2008
Polymorphisms in AHI1 are not associated with type 2 diabetes or related phenotypes in Danes: non-replication of a genome-wide association result
J Holmkvist, S Anthonsen, L Wegner, et al.
Diabetes, Obesity & Metabolism
|
April 13, 2010
Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus
S B Petersen, J Kildegaard, F S Nielsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 5, 2014
Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial
R K Simmons, A H Carlsen, S J Griffin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 10, 2016
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus
T M Jensen, D Vistisen, T Fleming, et al.
Diabetologia
|
April 25, 2013
The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status
A Heraclides, T M Jensen, S S Rasmussen, et al.
Diabetologia
|
November 19, 2011
Common variation in oxidative phosphorylation genes is not a major cause of insulin resistance or type 2 diabetes
L S Snogdal, M Wod, N Grarup, et al.
Diabetologia
|
May 1, 2009
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction
T Sparsø, N Grarup, C Andreasen, et al.
Diabetologia
|
June 24, 2008
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation
T Sparsø, G Andersen, A Albrechtsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 13, 2015
The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study
C S Hansen, T M Jensen, J S Jensen, et al.
Page
of 14